Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,693.27 +53.41 (+0.08%) CMC Crypto 200
1,425.10 -3.47 (-0.24%)
Summit Therapeutics Inc. (SMMT)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.10B |
| Enterprise value | 6.05B |
| Trailing P/E | 22.86 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 137.90 |
| Enterprise value/revenue | 6.43k |
| Enterprise value/EBITDA | -5.32 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.13 |
| 52-week change 3 | 366.94% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 11.25 |
| 52-week low 3 | 1.52 |
| 50-day moving average 3 | 4.22 |
| 200-day moving average 3 | 3.09 |
Share statistics
| Avg vol (3-month) 3 | 3.56M |
| Avg vol (10-day) 3 | 10.36M |
| Shares outstanding 5 | 701.98M |
| Implied shares outstanding 6 | 897.2M |
| Float 8 | 73.34M |
| % held by insiders 1 | 88.14% |
| % held by institutions 1 | 7.23% |
| Shares short (15 May 2024) 4 | 22.57M |
| Short ratio (15 May 2024) 4 | 11.39 |
| Short % of float (15 May 2024) 4 | 27.08% |
| Short % of shares outstanding (15 May 2024) 4 | 3.21% |
| Shares short (prior month 15 Apr 2024) 4 | 22.9M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -33.27% |
| Return on equity (ttm) | -130.59% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -114.75M |
| Net income avi to common (ttm) | -116.03M |
| Diluted EPS (ttm) | 0.38 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 156.68M |
| Total cash per share (mrq) | 0.22 |
| Total debt (mrq) | 109.52M |
| Total debt/equity (mrq) | 247.73% |
| Current ratio (mrq) | 6.97 |
| Book value per share (mrq) | 0.06 |
Cash flow statement
| Operating cash flow (ttm) | -93.76M |
| Levered free cash flow (ttm) | -527.61M |
© 2024 Yahoo. All rights reserved.